Chenguang Biotech Group (300138) — Free Cash Flow Generation Index

Latest as of September 2025: 0.93x

Chenguang Biotech Group (300138) has a Free Cash Flow Generation Index of 0.93x as of September 2025. Free cash flow of CN¥487.33 Million represents 1% of operating cash flow (CN¥524.96 Million). Explore 300138 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.93x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥487.33 Million
CNY

Operating Cash Flow

CN¥524.96 Million
CNY

Capital Expenditures

CN¥37.63 Million
CNY

Chenguang Biotech Group Free Cash Flow Generation Index (2008–2022)

Historical FCF Generation Index trend for Chenguang Biotech Group across 7 annual periods. For the full cash flow conversion analysis, see 300138 operating cash flow.

Annual Free Cash Flow Generation for Chenguang Biotech Group (2008–2022)

Year-by-year Free Cash Flow Generation Index for Chenguang Biotech Group. Check cash flow reinvestment rate of Chenguang Biotech Group to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2022 0.76x CN¥558.78 Million CN¥734.81 Million CN¥176.03 Million ▲ +122.4%
2021 -3.39x CN¥-216.92 Million CN¥63.90 Million CN¥280.82 Million ▼ -2042.1%
2020 0.17x CN¥92.54 Million CN¥529.41 Million CN¥436.88 Million ▼ -79.8%
2014 0.87x CN¥236.33 Million CN¥272.96 Million CN¥36.62 Million ▲ +171.5%
2011 -1.21x CN¥-99.54 Million CN¥82.18 Million CN¥181.72 Million ▲ +16.8%
2009 -1.46x CN¥-39.67 Million CN¥27.23 Million CN¥66.90 Million ▲ +22.3%
2008 -1.87x CN¥-16.99 Million CN¥9.06 Million CN¥26.05 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).